Recomendados
Recomendados
Más contenido relacionado
La actualidad más candente
La actualidad más candente (20)
Similar a Engagement within the new system
Similar a Engagement within the new system (20)
Más de PM Society
Más de PM Society (17)
Último
Último (20)
Engagement within the new system
- 1. Engagement within the new system Paul McManus, Lead Pharmacist | Specialised Commissioning
- 2. Engagement within the new system Paul McManus Lead pharmacist - specialised services South Yorkshire and Bassetlaw Area Team ABPI Regional event June 2013
- 3. NHS | Presentation to [XXXX Company] | [Type Date]3
- 4. Opportunities for engagement Product specific National • research • pipeline • commissioning • value • price • placement 4 Local • implementation • price • priorities • problems
- 5. Medicines optimisation Medicines still most common therapeutic intervention and biggest cost after staff, but, for example: • 30 to 50% not taken as intended • Patients have insufficient supporting information • UK Literature suggests 5 to 8% of hospital admissions due to preventable adverse effects of medicines • Medication errors across all sectors and age groups at unacceptable levels • Medicines wastage in primary care: £300M pa with £150M pa avoidable • Relatively little effort towards understanding clinical effectiveness of medicines in real practice • The threat of antimicrobial resistance
- 6. National Reporting and Learning System for England and Wales Types of incidents 2005-10 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
- 7. NRLS in England and Wales medication incident reports 2005 - 10 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
- 8. NRLS – who is reporting incidents? 8 Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
- 9. NRLS – Critical medicines Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012 NRLS – Critical medicines
- 10. NRLS – Error category Cousins D, Gerrett D, Warner B. Br J Clin Pharmacol. 2012
- 12. A strategy might include… • Patient engagement • Collaborative working across health economies • Improving outcomes • Value for money • Partnership with industry • Medicines pathway • Safety and assurance 12 Information and technology
- 13. What can we do? • Be an active commissioner • Ensure contact at right level and make meetings productive for all • Look for ways to best use skills and resources available • Think beyond individual products • Start talking 13
- 14. Engagement within the new system paulmcmanus@nhs.net 14